
JVP's Four Q1 Exits Signal VC Pivot From AI Research to Deployment Harvests
Jerusalem Venture Partners recorded four exits in Q1 2026, including the Covera Health-Medmo diagnostic imaging merger, marking a broader shift in venture capital from early-stage AI research funding to harvesting deployment-phase products. VC capital recycled from 2018-2022 enterprise data vintages is now flowing into operational AI across healthcare, fintech, and automotive. Two timelines are diverging: commodity AI applications shipping in H2 2026 and frontier physical-world systems arriving




